ANIKA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.59 USD | +4.15% |
|
+7.86% | +21.76% |
| 03-14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
| 03-13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
Chart calendar Anika Therapeutics, Inc.
01bb5f928db8d4e063860afc5e6ad51d.fz3dOqL492sReOvCLBUupJrZuEucfgNrg_JfrgfCNys.TXuaQOablCBmTb2pQ1lly-muwiLYBnQO6ccymEi2fGkwdLgLzoLGKlwOsg~6cd56932fc5a0957a4a7d76241d650aa
Upcoming events on Anika Therapeutics, Inc.
Past events on Anika Therapeutics, Inc.
| 08/04/2024 19:15 | Needham Healthcare Conference |
| 13/03/2024 21:00 | Q4 2023 Earnings Call |
| 13/03/2024 20:05 | Q4 2023 Earnings Release |
| 14/02/2024 23:40 | American Academy of Orthopedic Surgeons Meeting |
| 13/02/2024 17:30 | American Academy of Orthopedic Surgeons Meeting |
| 29/11/2023 19:50 | Piper Sandler Healthcare Conference |
| 15/11/2023 14:00 | Stephens Investment Conference |
| 02/11/2023 21:30 | Q3 2023 Earnings Call |
| 02/11/2023 20:05 | Q3 2023 Earnings Release |
| 21/09/2023 15:45 | Sidoti Small Cap Conference |
| 19/09/2023 | Orthopaedic Summit |
| 13/09/2023 | Barrington Virtual Fall Investor Conference |
| 08/08/2023 22:00 | Q2 2023 Earnings Call |
| 08/08/2023 21:05 | Q2 2023 Earnings Release |
| 14/06/2023 14:00 | Annual General Meeting |
| 09/05/2023 22:00 | Q1 2023 Earnings Call |
| 09/05/2023 21:05 | Q1 2023 Earnings Release |
| 20/04/2023 17:45 | Needham Healthcare Conference |
| 22/03/2023 13:15 | Sidoti Spring Small-Cap Conference |
| 09/03/2023 15:00 | American Academy of Orthopaedic Surgeons Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 115 112 1.96% | 130 131 -0.62% | 148 144 2.62% | 156 154 1.24% | 167 165 0.95% | 170 |
|
EBITDA Million USD | Released Forecast Spread | 49,2 47,8 2.91% | 23,9 24,8 -3.36% | 16,4 18,8 -12.74% | 12,6 12,7 -0.83% | 15,5 12,0 29.71% | 26,2 |
|
EBIT Million USD | Released Forecast Spread | 37,1 37,1 -0.02% | -28,3 -11,6 -143.88% | 2,62 6,51 -59.84% | -19,4 -14,7 -32.08% | -87,6 -29,8 -193.75% | -8,25 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 36,1 39,0 -7.36% | -28,6 -11,8 -141.69% | 2,43 6,44 -62.34% | -18,7 -17,5 -7.4% | -85,3 -21,3 -300.29% | -3,42 |
|
Net income Million USD | Released Forecast Spread | 27,2 29,0 -6.34% | -24,0 -9,74 -146.3% | 4,13 5,78 -28.43% | -14,9 -13,7 -8.42% | -82,7 -18,4 -348.11% | -2,21 |
|
EPS USD | Released Forecast Spread | 1,89 2,04 -7.35% | -1,69 -0,69 -146.72% | 0,28 0,45 -38.24% | -1,02 -0,92 -10.87% | -5,64 -1,60 -251.77% | -0,15 |
| Announcement Date | 20/02/20 | 04/03/21 | 08/03/22 | 06/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 35,8 32,1 11.76% | 36,7 32,9 11.41% | 39,7 37,9 4.77% | 40,3 37,6 7.12% | 39,6 37,7 5.08% | 37,9 37,4 1.52% | 44,3 40,4 9.73% | 41,5 38,3 8.36% | 43,0 41,4 3.78% | 39,1 | 43,8 | 42,7 | 44,6 | 41,3 |
|
EBITDA Million USD | Released Forecast Spread | -0,20 0,71 -127.91% | 2,61 -0,33 885.54% | 4,42 0,79 462.34% | 4,05 1,00 305.81% | 1,38 2,02 -31.85% | -1,20 0,00 -60300% | 6,27 0,82 663.48% | 4,65 0,41 1041.1% | 5,80 2,25 157.46% | 4,44 | 7,95 | 7,07 | 6,76 | 6,09 |
|
EBIT Million USD | Released Forecast Spread | -9,12 -4,54 -100.98% | -3,55 -5,91 39.83% | -3,38 -3,95 14.5% | -5,80 -4,60 -25.99% | -6,67 -4,47 -49.27% | -12,6 -6,39 -96.5% | -3,63 -6,63 45.26% | -7,67 -7,07 -8.51% | -63,8 -5,98 -967.2% | -5,64 | -0,53 | -1,42 | -0,66 | -0,62 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,17 -5,15 -78.05% | -3,71 -5,83 36.39% | -3,29 -3,88 15.25% | -5,36 -4,54 -18.23% | -6,39 -4,37 -46.37% | -12,0 -6,20 -93.88% | -3,07 -6,38 51.91% | -7,04 -6,84 -2.92% | -63,2 -4,83 -1207.4% | -3,64 | 0,76 | -0,39 | -0,15 | -0,19 |
|
Net income Million USD | Released Forecast Spread | -5,79 -4,15 -39.57% | -2,93 -4,84 39.38% | -2,84 -3,28 13.4% | -4,18 -3,70 -12.79% | -4,91 -3,47 -41.45% | -10,4 -4,95 -109.26% | -2,74 -5,02 45.45% | -6,58 -5,47 -20.2% | -63,0 -3,84 -1542.05% | -2,71 | 0,79 | -0,20 | -0,10 | -0,17 |
|
EPS USD | Released Forecast Spread | -0,40 -0,27 -46.56% | -0,20 -0,33 40% | -0,20 -0,23 13.04% | -0,29 -0,25 -16% | -0,34 -0,24 -41.67% | -0,71 -0,34 -108.82% | -0,19 -0,34 44.66% | -0,45 -0,37 -20.54% | -4,30 -0,26 -1532.93% | -0,19 | 0,06 | -0,01 | -0,01 | -0,01 |
| Announcement Date | 08/03/22 | 05/05/22 | 03/08/22 | 08/11/22 | 06/03/23 | 09/05/23 | 08/08/23 | 02/11/23 | 13/03/24 | - | - | - | - | - |
More events
Past sector events for Anika Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ANIK Stock
- Calendar Anika Therapeutics, Inc.
